Un jeu d'échos intertextuels. L'évasion de Pierre et la mort du tyran (Actes 12)

La Bible est un immense trésor d'histoires racontées. De la Genèse à l'Apocalypse, chaque récit déploie un monde que le lecteur est invité à habiter. Une discipline récente, la narratologie, s'attache à étudier cet art millénaire du « raconter ». Qu'il soit romancier ou écrivain biblique, tout conteur utilise les mêmes outils : il construit une intrigue, il tisse un réseau de personnages, il induit un système de valeurs, il sollicite l'imaginaire du lecteur et le fait voyager dans l'espace et le temps... Sept biblistes présentent ici des « travaux pratiques » d'analyse narrative appliquée à la Bible. Après avoir été invité par Daniel Marguerat à «Entrer dans le monde du récit », le lecteur goûtera la magie du raconter : qu'ils aient été bergers ou érudits, les conteurs bibliques étaient des artistes !

BCG Moreau Rio de Janeiro: an oral vaccine against tuberculosis - review

The vaccine Bacillus of Calmette Guérin (BCG) was originally developed in France as an oral vaccine against tuberculosis. The oral use of this vaccine was replaced by the parenteral route in almost all countries after the Lubeck disaster. In contrast, Brazil retained the oral delivery of the vaccine until the mid-seventies when it was replaced by the intradermal route. This change in route of delivery was mainly secondary to pressure by medical practitioners based on the poor responses of oral immunized subjects to purified protein derivative (PPD) skin tests. Even after the change of route of delivery, Ataulpho de Paiva Foundation continued making the oral vaccine. Currently, BCG Moreau has been described as one of the most immunogenic and with fewer side effects than other BCGs. The genomics, proteomics and vaccine trials for oral BCG Moreau Rio de Janeiro are currently under investigation. In this review, we intend to describe the history of BCG Moreau Rio de Janeiro in Brazil.

Genetic characterization of St. Louis encephalitis virus isolated from human in São Paulo, Brazil

The molecular characterization of SPH253157, a new strain of St. Louis encephalitis virus (SLEV), isolated in 2004 from the first case of human infection recognized in the state of São Paulo, Brazil, is reported. The patient, presenting a febrile illness without neurological involvement, was hospitalized as a probable case of dengue fever. Genomic RNA was isolated from the supernatant of C6/36 cells infected with acute phase-serum specimen of the patient and the envelope gene was amplified by reverse-transcription-polymerase chain reaction. The complete nucleotide sequence of the envelope gene of this isolate was directly sequenced from the amplified products and compared with other Brazilian and American SLEV strains. Phylogenetic analyses were carried out under maximum likelihood criterion with outgroups both included and excluded. Outgroups comprised four flavivirus of the Japanese encephalitis group. Phylogeny also included Bayesian analysis. The results indicated that the new SLEV isolate belongs to lineage III, being closely related to an Argentinean strain recovered from Culex sp. in 1979. It is concluded that there are at least 3 lineages of SLEV in Brazil.